Atrys Health, S.A. (BME: ATRY)
Spain
· Delayed Price · Currency is EUR 3.150
+0.020 (0.64%)
Dec 20, 2024, 9:25 AM CET
Atrys Health Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 211.11 | 206.1 | 163.2 | 123.85 | 33.81 | 16.66 | Upgrade
|
| Revenue Growth (YoY) | 24.08% | 26.28% | 31.77% | 266.34% | 102.95% | 78.99% | Upgrade
|
| Cost of Revenue | 155.67 | 148.96 | 116.26 | 89.67 | 21.41 | 9.68 | Upgrade
|
| Gross Profit | 55.44 | 57.15 | 46.95 | 34.19 | 12.4 | 6.98 | Upgrade
|
| Selling, General & Admin | 1.66 | 1.95 | 2.58 | 0.68 | 0.21 | - | Upgrade
|
| Other Operating Expenses | 25.64 | 27.1 | 29.15 | 16.75 | 3 | 2.68 | Upgrade
|
| Operating Expenses | 55.94 | 58.73 | 57.7 | 38.22 | 9.19 | 4.58 | Upgrade
|
| Operating Income | -0.51 | -1.58 | -10.75 | -4.03 | 3.21 | 2.39 | Upgrade
|
| Interest Expense | -26.31 | -33.05 | -14.53 | -11.03 | -2.35 | -1.06 | Upgrade
|
| Interest & Investment Income | 0.37 | 0.63 | 2.91 | 1.85 | 0.21 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1.47 | -0.04 | -0.42 | -1.32 | -0.91 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.5 | 1.03 | -1.08 | 0.97 | -1.79 | 0.35 | Upgrade
|
| EBT Excluding Unusual Items | -23.42 | -33.01 | -23.88 | -13.57 | -1.63 | 1.68 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -11.3 | -3.76 | -1.48 | Upgrade
|
| Asset Writedown | -8.76 | -0.68 | -2.91 | -0.01 | - | -0 | Upgrade
|
| Pretax Income | -32.18 | -33.7 | -26.79 | -24.88 | -5.38 | 0.21 | Upgrade
|
| Income Tax Expense | -0.41 | -2.94 | -0.84 | -1.69 | 0.17 | 0.31 | Upgrade
|
| Earnings From Continuing Operations | -31.78 | -30.76 | -25.96 | -23.2 | -5.55 | -0.1 | Upgrade
|
| Earnings From Discontinued Operations | -7.56 | -15.14 | 2.55 | -0.05 | - | - | Upgrade
|
| Net Income to Company | -39.33 | -45.9 | -23.41 | -23.24 | -5.55 | -0.1 | Upgrade
|
| Minority Interest in Earnings | 0.27 | 0.31 | 0.26 | -0.01 | - | - | Upgrade
|
| Net Income | -39.07 | -45.59 | -23.15 | -23.26 | -5.55 | -0.1 | Upgrade
|
| Net Income to Common | -39.07 | -45.59 | -23.15 | -23.26 | -5.55 | -0.1 | Upgrade
|
| Shares Outstanding (Basic) | 76 | 76 | 68 | 50 | 28 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 76 | 76 | 68 | 50 | 28 | 21 | Upgrade
|
| Shares Change (YoY) | 6.53% | 11.15% | 35.64% | 77.58% | 31.93% | 10.32% | Upgrade
|
| EPS (Basic) | -0.51 | -0.60 | -0.34 | -0.46 | -0.20 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.51 | -0.60 | -0.34 | -0.46 | -0.20 | -0.00 | Upgrade
|
| Free Cash Flow | -17.12 | -7.34 | -22.2 | 0.47 | -4.59 | -1.77 | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.10 | -0.33 | 0.01 | -0.16 | -0.08 | Upgrade
|
| Gross Margin | 26.26% | 27.73% | 28.77% | 27.60% | 36.68% | 41.89% | Upgrade
|
| Operating Margin | -0.24% | -0.77% | -6.59% | -3.26% | 9.51% | 14.37% | Upgrade
|
| Profit Margin | -18.51% | -22.12% | -14.18% | -18.78% | -16.41% | -0.63% | Upgrade
|
| Free Cash Flow Margin | -8.11% | -3.56% | -13.60% | 0.38% | -13.58% | -10.64% | Upgrade
|
| EBITDA | 8.21 | 13.86 | 6.96 | 8.35 | 6.68 | 3.05 | Upgrade
|
| EBITDA Margin | 3.89% | 6.72% | 4.27% | 6.74% | 19.77% | 18.31% | Upgrade
|
| D&A For EBITDA | 8.71 | 15.44 | 17.71 | 12.39 | 3.47 | 0.66 | Upgrade
|
| EBIT | -0.51 | -1.58 | -10.75 | -4.03 | 3.21 | 2.39 | Upgrade
|
| EBIT Margin | -0.24% | -0.77% | -6.59% | -3.26% | 9.51% | 14.37% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 150.71% | Upgrade
|
| Revenue as Reported | 216.8 | 207 | 164.14 | 127.84 | 34.72 | 16.98 | Upgrade
|
| Advertising Expenses | - | 0.79 | 0.68 | 0.68 | 0.21 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.